Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q2 FY24 results · Jul–Sep 2023
Unichem Laboratories reported revenue from operations of ₹415.63 crore (up 26.4% from Q2 FY23) and net loss of ₹24.49 crore for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 415.63 | 328.82 | +26.4% | 423.19 | −1.8% |
| Other income | 5.54 | 9.21 | −39.9% | 8.63 | −35.9% |
| Total income | 421.16 | 338.02 | +24.6% | 431.82 | −2.5% |
| Profit before tax | (21.88) | (47.25) | Loss narrowed | 2.12 | Turned loss |
| Net profit for the period | (24.49) | (70.67) | Loss narrowed | (0.67) | Loss widened |
| EPS, basic (₹) | (4.38) | (10.04) | Loss narrowed | (0.09) | Loss widened |
| Net margin (%) | -5.9 | -21.5 | -0.2 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 333.83 | 265.64 | +25.7% | 346.67 | −3.7% |
| Other income | 7.58 | 10.78 | −29.7% | 5.83 | +30.1% |
| Total income | 341.41 | 276.42 | +23.5% | 352.49 | −3.1% |
| Profit before tax | (30.81) | (54.85) | Loss narrowed | (15.70) | Loss widened |
| Net profit for the period | (30.81) | (75.46) | Loss narrowed | (15.70) | Loss widened |
| EPS, basic (₹) | (4.38) | (10.72) | Loss narrowed | (2.23) | Loss widened |
| Net margin (%) | -9.2 | -28.4 | -4.5 |
Consolidated
- Filed with BSE
- 02 Nov 2023, 10:49 IST
- Board meeting
- 01 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 02 Nov 2023, 10:49 IST
- Board meeting
- 01 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE